142 related articles for article (PubMed ID: 15079036)
21. Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus.
Sander T; Sprenger A; Marti S; Naumann T; Straumann D; Helmchen C
J Neurol; 2011 Apr; 258(4):618-22. PubMed ID: 21057959
[TBL] [Abstract][Full Text] [Related]
22. The mixed blessing of treating symptoms in acute vestibular failure--evidence from a 4-aminopyridine experiment.
Beck R; Günther L; Xiong G; Potschka H; Böning G; Bartenstein P; Brandt T; Jahn K; Dieterich M; Strupp M; la Fougère C; Zwergal A
Exp Neurol; 2014 Nov; 261():638-45. PubMed ID: 25157903
[TBL] [Abstract][Full Text] [Related]
23. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
[TBL] [Abstract][Full Text] [Related]
24. Study of pursuit and vestibulo-ocular cancellation.
Mai M; Dayal VS; Tomlinson RD; Farkashidy J
Otolaryngol Head Neck Surg; 1986 Dec; 95(5):589-91. PubMed ID: 3108798
[TBL] [Abstract][Full Text] [Related]
25. The effect of alcohol on the vestibulo-ocular reflex and gaze regulation.
Takahashi M; Akiyama I; Tsujita N; Yoshida A
Arch Otorhinolaryngol; 1989; 246(4):195-9. PubMed ID: 2597079
[TBL] [Abstract][Full Text] [Related]
26. Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine.
Feil K; Claaßen J; Bardins S; Teufel J; Habs M; Kalla R; Strupp M
J Neurol; 2013 May; 260(5):1426-8. PubMed ID: 23595790
[No Abstract] [Full Text] [Related]
27. Impact of 4-aminopyridine on vestibulo-ocular reflex performance.
I Gusti Bagus M; Gordy C; Sanchez-Gonzalez R; Strupp M; Straka H
J Neurol; 2019 Sep; 266(Suppl 1):93-100. PubMed ID: 31270663
[TBL] [Abstract][Full Text] [Related]
28. Modelling drug modulation of nystagmus.
Glasauer S; Rössert C
Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
[TBL] [Abstract][Full Text] [Related]
29. Dalfampridine in patients with downbeat nystagmus--an observational study.
Claassen J; Feil K; Bardins S; Teufel J; Spiegel R; Kalla R; Schneider E; Jahn K; Schniepp R; Strupp M
J Neurol; 2013 Aug; 260(8):1992-6. PubMed ID: 23589193
[TBL] [Abstract][Full Text] [Related]
30. A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Claassen J; Spiegel R; Kalla R; Faldon M; Kennard C; Danchaivijitr C; Bardins S; Rettinger N; Schneider E; Brandt T; Jahn K; Teufel J; Strupp M; Bronstein A
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1392-9. PubMed ID: 23813743
[TBL] [Abstract][Full Text] [Related]
31. The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus.
Glasauer S; Rössert C; Strupp M
Ann N Y Acad Sci; 2011 Sep; 1233():162-7. PubMed ID: 21950989
[TBL] [Abstract][Full Text] [Related]
32. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Kalla R; Teufel J; Feil K; Muth C; Strupp M
J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
[TBL] [Abstract][Full Text] [Related]
33. Role of the cerebellar flocculus region in the coordination of eye and head movements during gaze pursuit.
Belton T; McCrea RA
J Neurophysiol; 2000 Sep; 84(3):1614-26. PubMed ID: 10980031
[TBL] [Abstract][Full Text] [Related]
34. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
[TBL] [Abstract][Full Text] [Related]
35. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus.
Dieterich M; Straube A; Brandt T; Paulus W; Büttner U
J Neurol Neurosurg Psychiatry; 1991 Jul; 54(7):627-32. PubMed ID: 1654396
[TBL] [Abstract][Full Text] [Related]
36. Eye movement deficits following ibotenic acid lesions of the nucleus prepositus hypoglossi in monkeys II. Pursuit, vestibular, and optokinetic responses.
Kaneko CR
J Neurophysiol; 1999 Feb; 81(2):668-81. PubMed ID: 10036269
[TBL] [Abstract][Full Text] [Related]
37. Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine.
Sprenger A; Rambold H; Sander T; Marti S; Weber K; Straumann D; Helmchen C
Neurology; 2006 Sep; 67(5):905-7. PubMed ID: 16966567
[TBL] [Abstract][Full Text] [Related]
38. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
Glasauer S; Strupp M; Kalla R; Büttner U; Brandt T
Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
Strupp M; Kalla R; Claassen J; Adrion C; Mansmann U; Klopstock T; Freilinger T; Neugebauer H; Spiegel R; Dichgans M; Lehmann-Horn F; Jurkat-Rott K; Brandt T; Jen JC; Jahn K
Neurology; 2011 Jul; 77(3):269-75. PubMed ID: 21734179
[TBL] [Abstract][Full Text] [Related]
40. Eye movements in cocaine abusers.
Demer JL; Volkow ND; Ulrich I; Krajewski K; Davis CM; Porter FI
Psychiatry Res; 1989 Aug; 29(2):123-36. PubMed ID: 2798592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
